Anti-NY-ESO-1 TCR-gene engineered lymphocytes

TCR-T cells targeting NY-ESO-1 · Hadassah Medical Organization

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-NY-ESO-1 TCR-gene engineered lymphocytes, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers [Phase 1, Phase 2]

See pricing